EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications

Justyna Pilch, Mateusz Krzyzinski, Anna Markiewicz, Przemyslaw Biecek, Antonina J Mazur, Bozena Romanowska-Dixon, Mai P Hoang, Piotr Donizy

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.13.45 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Justyna Pilch and 7 co-authors. Institution: Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland. Major MEDLINE topics: Melanoma, Microphthalmia-Associated Transcription Factor, Uveal Neoplasms. Cited 3 times so far (Crossref); 71 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Microphthalmia-associated transcription factor (MITF) regulates melanocyte differentiation, proliferation, and survival, intersecting with oncogenic and tumor-suppressive pathways. However, its prognostic significance in uveal melanoma (UM) remains unexplored in large cohorts. This study examines MITF's prognostic value and its correlation with key molecular markers-BAP1, preferentially expressed antigen in melanoma (PRAME), deoxythymidylate kinase (dTYMK), and poly(ADP-ribose) polymerase 1 (PARP1).

Methods

Immunostaining for MITF, BAP1, dTYMK, PARP1, and PRAME was performed on tissue microarrays from 154 UM cases with no prior therapy. We correlated MITF level with detailed clinicopathologic variables and patient outcomes. Scoring of MITF immunostainings was done using the H-score with further dichotomization into two subgroups with low (H-score < 15) and high level (H-score ≥ 15) using the Contal-O'Quinley method.

Results

Patients with low MITF level were characterized by shorter cancer-specific overall (P = 0.019) and disease-free survival (P = 0.0038). Low MITF level was significantly correlated with the presence of distant metastases (P = 0.005), BAP1-negative tumors (P = 0.023), higher largest basal diameter (P < 0.001), and tumor-associated macrophages immune response (P < 0.001). On the other hand, high MITF level was correlated with a higher mitotic index (P = 0.033) and enhanced replicating potential of tumoral cells significantly correlated with dTYMK and PARP1 level (P < 0.001).

Conclusions

MITF delineates two UM subpopulations: (1) MITF-low tumors-slow proliferators with high invasive potential and inflammatory phenotype, and (2) MITF-high tumors-rapidly dividing cells with lower invasiveness and immunosuppressive properties. These findings suggest potential therapeutic strategies, including MITF re-induction for MITF-low tumors and dTYMK/PARP1 inhibitors for MITF-high UM.

Subjects

MeSH terms (MEDLINE)

MelanomaMicrophthalmia-Associated Transcription FactorUveal NeoplasmsHumansFemaleMaleUveal MelanomaPrognosisMiddle AgedAgedBiomarkers, TumorAdultAged, 80 and overImmunohistochemistryTissue Array AnalysisTumor Suppressor ProteinsPoly (ADP-Ribose) Polymerase-1Ubiquitin Thiolesterase

Substances

Microphthalmia-Associated Transcription FactorMITF protein, humanBiomarkers, TumorBAP1 protein, humanTumor Suppressor ProteinsPoly (ADP-Ribose) Polymerase-1Ubiquitin ThiolesterasePARP1 protein, human

Authors and institutions

  • Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland.
  • Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.
  • Jagiellonian University Medical College, Faculty of Medicine, Department of Ophthalmology and Ocular Oncology, Krakow, Poland.
  • Department of Cell Pathology, Faculty of Biotechnology, University of Wroclaw, Poland, Wroclaw, Poland.
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Department of Pathology and Clinical Cytology, Jan Mikulicz-Radecki University Hospital, Wroclaw, Poland.

Cite

APA

Pilch, J., Krzyzinski, M., Markiewicz, A., Biecek, P., Mazur, A. J., Romanowska-Dixon, B., Hoang, M. P., & Donizy, P. (2025). Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.13.45

Vancouver

Pilch J, Krzyzinski M, Markiewicz A, Biecek P, Mazur AJ, Romanowska-Dixon B, et al. Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.13.45

BibTeX
@article{Pilch2025,
  author = {Pilch, Justyna and Krzyzinski, Mateusz and Markiewicz, Anna and Biecek, Przemyslaw and Mazur, Antonina J and Romanowska-Dixon, Bozena and Hoang, Mai P and Donizy, Piotr},
  title = {Dualistic Role of MITF in Uveal Melanoma: Defining Two Distinct Cellular Subpopulations With Prognostic and Therapeutic Implications},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.13.45}
}
Start for free →